Delivery Order SPE2DB20D3101-SPE2DB25FRUG1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $12,152.93 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and extending through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $81,786.40. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Jardiance 25 mg tablets (90-count) at a ceiling value of $6,083.49. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $5,537.03. This is a non-set-aside delivery order with an ultimate completion date of September 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $9,966.32. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $3,289.88 under firm fixed pricing. This contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-set-aside and was competitively awarded, with the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,135.93. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), does not utilize a set-aside designation and represents a competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $8,059.70. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUG1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90s, with a ceiling value of $50,074.67. This firm fixed-price delivery order, which is set to complete by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive DLA pharmaceutical prime vendor contract. The company supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. This delivery order for Jardiance, a diabetes management medication, exemplifies the company's ongoing role in fulfilling federal pharmaceutical supply requirements under its primary global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.1k | 9/3/25 |